Podcasts about Intuitive Surgical

Alphabet's ad business keeps putting up huge numbers, but a DOJ breakup, generative AI threats, and potential macro slowdown loom. (00:21) Jason Moser and Asit Sharma discuss: - Alphabet's resilient ad business, and what parts of the company might be most interesting if the break-up happens. - Tesla's rough quarter, and why the Model Y release is a key moment for the company's auto thesis. - Chipotle's burrito slowdown, how ServiceNow's government contracts are holding up, and the latest with Intuitive Surgical. (19:11) Malcolm Ethridge comes back on the show to talk big tech and his favorite recession-proof stocks. (34:48) Asit and Jason break down two stocks on their radar: Nasdaq and Adobe. Stocks discussed: GOOG, GOOGL, TSLA, NOW, ISRG, ACN, NFLX, SPOT, NDAQ, ADBE. Host: Dylan Lewis Guests: Jason Moser, Asit Sharma, Malcolm Ethridge Engineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

Follow along and subscribe/rate/review at https://www.briancovey.com/podcast/In this episode of The Competitive Edge, Brian Covey welcomes high-performance coach Kristy Kuhl, whose journey from a one-stoplight town to corporate sales superstar and now elite coach serves as a blueprint for self-alignment and transformation.Kristy shares her transition from the high-stress world of medical device sales — notably with Intuitive Surgical's da Vinci robot — to a more purpose-driven life centered on coaching. Her story is a powerful reminder that success without alignment can lead to burnout. Kristy introduces listeners to the power of Human Design, situational leadership, and the role of fitness in mental clarity and peak performance.Together, Brian and Kristy unpack strategies for building self-awareness, curating your circle of influence, and creating a life and career in sync with your values. From navigating social media with intention to developing platforms that serve others authentically, this episode is packed with tools and takeaways for leaders, entrepreneurs, and anyone ready to grow.Tune in for an inspiring and practical conversation that will challenge you to look inward, take aligned action, and surround yourself with the right people to elevate your game.

  During this Episode, Russ discusses the Large Unprotected Covered Call or L.U.C.C trading strategy.  Large in that the share price is large (think Costco, Netflix, Intuitive Surgical, etc.).  Unprotected in the sense that the strategy doesn't buy insurance in  a protective put option at a lower price (like a collar trade).  It is essentially a large, In The Money (“ITM”) covered call.  It is protected from volatility and the large upfront cost by how far down in the money you select, and you give back some of the premium (the intrinsic value portion) - though give back is a misnomer in that it all happens automatically at the brokerage.  Several examples are given.    Don't forget to subscribe to the show!

Get 25% off an annual membership with this link: https://ko-fi.com/chipstockinvestor/link/MARKETMELTDOWN25In this episode of Chip Stock Investor, we dive into fresh earnings reports from two robotics-heavyweights: Tesla and Intuitive Surgical. Is Tesla's Q1 dip a normal cycle downturn or the start of something bigger? We explore key data points like vehicle deliveries, energy revenue, and Elon's political impact. Then we turn to Intuitive Surgical's solid performance, procedure growth, and how tariffs might affect its margins. Two very different businesses, both navigating big challenges and big opportunities.Sign Up For Our Newsletter: https://mailchi.mp/b1228c12f284/sign-up-landing-page-short-formJoin us on Discord with Semiconductor Insider: https://ko-fi.com/chipstockinvestor/tiersSupercharge your analysis with AI! Get 15% of your membership with our special link here: https://finchat.io/csi/Safeguard your personal information with Aura's monitoring service – try it free for two weeks and see where your data might be lurking: https://aura.com/chipstockinvestor

Carson Group's Ryan Detrick and Payne Capital's Courtney Garcia break down today's huge rally, with the major averages regaining all of Monday's big losses. A packed slate of earnings led by Tesla. Wedbush's Dan Ives and former Tesla President Jon McNeill give instant reaction to the EV-maker's numbers. On the macro front, Jefferies' David Zervos discusses Fed policy and the latest Trump vs. Powell tensions. Other earnings include Enphase, Baker Hughes, Capital One, Intuitive Surgical and SAP. Plus, Morgan gives key takeaways from defense sector earnings. 

In this episode of Medsider Radio, we sat down with Ryan Rhodes, CEO of EDAP TMS. EDAP is changing prostate cancer treatment through Focal One, a robotic high-intensity focused ultrasound (HIFU) system that doesn't require the use of surgery or radiation. Ryan has over 30 years of experience in market development, with two decades focused on medical robotics. Before EDAP, Ryan was CEO of Restoration Robotics, where he guided the company to a successful merger with Venus Concept. He spent 13+ years at Intuitive Surgical, establishing the global Urology franchise, which became the company's entry point for broader adoption of the da Vinci system. He also spent 11 years at Ethicon (J&J) in sales, marketing, and market development.In this interview, Ryan challenges founders to ask: Are you creating a scalable medtech solution or a product with limited growth potential? He unpacks why standardization and scalability are critical for adoption, how clinical data fuels credibility and reimbursement, and why early adopters take the biggest risks — but also reap the biggest rewards.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Ryan Rhodes.

In this week's Digital Health Roundup, Medtech Insight's Marion Webb highlights her interview with Gary Guthart, CEO of Intuitive Surgical about the new da Vinci 5 surgical robot and the future of robotics in surgery. Brian Bossetta talks about the recently FDA-cleared patient monitoring system that sends vital signs directly to clinician staff. Elizabeth Orr discusses an FDA warning letter to Exer Labs and Shubham Singh discusses Roche's new NGS Prototype, expected to challenge Illumina.

Eric Veiel, head of Global Investments and CIO at T. Rowe Price Associates, chats with Gary Guthart, CEO of Intuitive Surgical, about advancements in robotic surgery, the company's expanding ecosystem, and his journey to becoming CEO.

March 31, 2025 | Season 5 | Episode 11The weakening US dollar may be the canary in the coal mine for broader market troubles ahead. Despite conditions that should strengthen it—high interest rates, geopolitical uncertainty, America's military dominance—the greenback has fallen against nearly every major global currency in 2025. This unusual pattern suggests foreign investors are losing confidence, potentially withdrawing the capital that traditionally supports US stocks and bonds.Meanwhile, markets are bracing for what President Trump calls "Liberation Day" on April 2nd, when new tariff policies are expected. Reports of a possible 20% universal tariff on all imports have sent tremors through Wall Street, with Goldman Sachs cutting its S&P target twice this month. The potential $11,000 price increase on imported vehicles illustrates the real-world impact these policies could have on consumers and businesses alike.The artificial intelligence sector appears to be entering a crucial transition phase where investors demand tangible returns on massive investments. Drawing fascinating parallels to the 1990s internet boom, experts remind us that only 1% of today's internet giants existed just 2.5 years after Netscape Navigator launched. Today's market leaders may not be tomorrow's AI champions, suggesting opportunities in companies like Snowflake, Intuitive Surgical, and cybersecurity firms that will protect increasingly vulnerable AI systems.For fixed income investors, discussions about potentially eliminating municipal bond tax exemptions to fund Trump tax cut extensions present both risk and opportunity. While concerning, municipal bonds have already priced in some of this uncertainty, potentially creating value for long-term investors willing to weather the volatility.As we navigate these complex market currents, watch the dollar's trajectory carefully—it may tell us more about where markets are heading than traditional economic indicators. What signals are you watching as we enter this period of heightened uncertainty?** For informational and educational purposes only, not intended as investment advice. Views and opinions are subject to change without notice. For full disclosures, ADVs, and CRS Forms, please visit https://heroldlantern.com/disclosure **To learn about becoming a Herold & Lantern Investments valued client, please visit https://heroldlantern.com/wealth-advisory-contact-formFollow and Like Us on Youtube, Facebook, Twitter, and LinkedIn | @HeroldLantern

Vous ne savez pas dans quoi investir en Bourse ? Des gérants vous donnent des idées de valeurs, secteurs, matières premières... Aujourd'hui, c'est Guillaume Di Pizio, responsable de la gestion chez Dauphine AM.

On the first call since Kroger CEO Rodney McMullen's departure, not a mention of the former CEO was heard. (00:21) Nick Sciple and Ricky Mulvey discuss: - Kroger's business results. - Why some investors are becoming more pessimistic about Abercrombie & Fitch. - A small-cap tobacco company playing in a fast-growing trend. Then, (17:22) Karl Thiel joins Mary Long to discuss advanced-robotics company, Intuitive Surgical. Companies discussed: KR, ANF, TPB, ISRG, GOOG, GOOGL Host: Ricky Mulvey Guests: Nick Sciple, Mary Long, Karl Thiel Engineers: Dan Boyd, Rick Engdahl Learn more about your ad choices. Visit megaphone.fm/adchoices

Join us on Discord with Semiconductor Insider:https://ko-fi.com/chipstockinvestor/tiersOur "forever healthcare stock" Intuitive Surgical had a great 2024. Is it too late to buy in 2025? Chip Stock Investor Kasey Rossolillo discusses recent advances with the da Vinci surgical robot, why the stock always seems expensive, but why it remains a favorite for the long term.Supercharge your analysis with AI! Get 15% of your membership with our special link here:https://finchat.io/csi/Safeguard your personal information with Aura's monitoring service – try it free for two weeks and see where your data might be lurking:https://aura.com/chipstockinvestor

Es gibt Unternehmen, die rasant wachsen. Es gibt Unternehmen, die den Weltmarkt in einer lukrativen Nische dominieren. Es gibt Unternehmen, die Traummargen einfahren und schuldenfrei sind. Und es gibt Intuitive Surgical, den Pionier bei OP-Robotern, auf den all dies zutrifft. GEWINN hat sich die Aktie genauer angeschaut.

In this episode, Scott Becker examines the struggles of major healthcare stocks like HCA, Universal Health Services, and Intuitive Surgical amid concerns over healthcare reimbursement and cost containment.

In this episode, Scott Becker examines the struggles of major healthcare stocks like HCA, Universal Health Services, and Intuitive Surgical amid concerns over healthcare reimbursement and cost containment.

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Philipp Vetter über knappe Kassen bei Nikola, den Puma-Absturz und eine Achterbahnfahrt bei Intuitive Surgical. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) [Hier] (https://open.spotify.com/playlist/6zxjyJpTMunyYCY6F7vHK1?si=8f6cTnkEQnmSrlMU8Vo6uQ) findest Du die Samstagsfolgen Klassiker-Playlist auf Spotify! Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Rafael Ojeda, analista independiente, pone el foco en Verizon, American Express, Intuitive Surgical, Texas Instruments y Boeing.

European bourses are mixed, tech-heavy NQ slightly underperforms after SK Hynix highlights demand concerns.USD flat with price action contained in quiet trade; markets await US President Trump at Davos.Bonds hold a bearish bias into Trump though benchmarks bounced briefly on strong UK & French supply, but returned to session lows.Crude a little firmer, Base metals continue to be subdued by Trump tariff threats.Looking ahead, US Initial Jobless Claims, Australian PMI, Japanese CPI, Canadian Retail Sales, CBRT Policy Announcement, Supply from the US, Speakers including SNB Chair Schlegel & US President Trump.Earnings from GE Aerospace, American Airlines Group Inc., Freeport-McMoRan Copper & Gold, Huntington Bancshares Incorporated, Texas Capital Bancshares, Elevance Health, Alaska Air Group, Union Pacific Corp., Texas Instruments Incorporated, Intuitive Surgical, CSX Corp.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

Miramos a valores como American Airlines, Freeport McMoran, Electronic Arts, Intuitive Surgical y Texas Instruments. Con Rafael Damborenea, profesor de finanzas en Eude Bussines School.

In der neuesten Folge von "Money Train" begrüßen wir Martin Weiß, stellvertretender Chefredakteur bei DER AKTIONÄR. Gemeinsam analysieren wir die aktuelle Lage bei Intel, Intuitive Surgical und UnitedHealth – drei Unternehmen, deren Kursverläufe kaum unterschiedlicher sein könnten. Auf der einen Seite steht Intuitive Surgical, das ein phänomenales Jahr hinter sich hat. Doch mit einem hohen KGV von rund 75 stellt sich die Frage: Ist die Aktie inzwischen zu teuer bewertet? Ein nahezu gegenteiliges Bild zeigt sich bei Intel: Das Unternehmen musste im vergangenen Jahr einige Rückschläge hinnehmen, doch dank solider Investitionen und einer moderaten Bewertung bleibt die Hoffnung auf eine Erholung groß. Auch die Aktie von UnitedHealth wirft Fragen auf: Wie hoch ist das tatsächliche Potenzial, und wie behauptet sich der Branchenführer gegenüber der Konkurrenz? Hinweis: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlageempfehlungen dar. Die Moderatoren oder der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen.

Unser Partner Scalable Capital ist der einzige Broker, den du brauchst. Inklusive Trading-Flatrate, Zinsen und Portfolio-Analysen. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch. Das Buch zum Podcast? Jetzt lesen. Zinsen fallen endlich. Goldman Sachs, Citigroup, Wells Fargo und BlackRock steigen trotzdem. Denn IB war 2024 profitabel möglich. Ansonsten planen SGS & Bureau Veritas eine Giga-Fusion, Bayer verliert und gewinnt Rechtsstreit & Intuitive Surgical wächst. McDonald's (WKN: 856958) hatte ein schlechtes 2024. Ein neuer Giga-Deal in Südamerika, kostenlose Tinder-Abos für Kunden und ein Double Cheeseburger für 1 $ sollen's richten. Rumble (WKN: A3DRQQ) ist irgendwo zwischen MicroStrategy und Truth Social. Was dafür spricht: Giga-Investments, Deals mit El Salvador, krasse Investoren. Was dagegen spricht: Harte Zahlen. Diesen Podcast vom 16.01.2025, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

Alissa Coram and Ed Carson analyze Wednesday's market action and discuss key stocks to watch on Stock Market Today.

Alissa Coram and Justin Nielsen analyze Monday's market action and discuss key stocks to watch on Stock Market Today.

Where does Iman Jeddi see Intuitive's da Vinci 5 - and robotics - fit into the future of surgery? In this episode of IntuitiveTalks, Iman Jeddi, PhD, senior vice president and general manager of the company's multi port platform, shares a vision for the future of surgery where robotic systems elevate the performance of surgeons and deliver greater care equity. Jeddi's career started in biomedical engineering, taking her through several start-ups and ultimately, Abbott. Her lifelong career goal to create technology that improved care for the many led her to join Intuitive Surgical in 2013. Jeddi has held multiple leadership roles in engineering, operations, and quality. Prior to taking her current post, Jeddi was general manager of the single-port platform, da Vinci SP, so she brings a uniquely comprehensive perspective to the company's surgical robotic portfolio. The interview begins and ends with a personal story illustrating her belief in building medical devices and tools that can deliver better care for as many patients as possible. Thank you to Aptyx for sponsoring this episode of IntuitiveTalks! Please visit www.aptyx.com to learn more about how Aptyx can help you manufacture your competitive edge. Thank you for listening to the IntuitiveTalks Podcast. Subscribe to this podcast on every major podcast platform.

Ed Carson and Alissa Coram walk through Tuesday's market action and discuss key stocks to watch in Stock Market Today.

In this episode, Scott Becker discusses the latest successes of Apple, Amazon, and Intuitive Surgical, highlighting strong performances under exceptional leadership. From Apple’s record revenues to Amazon’s impressive earnings and Intuitive’s standout growth, Scott shares insights on what makes these CEOs and companies ones to watch.

In this episode, Scott Becker discusses the latest successes of Apple, Amazon, and Intuitive Surgical, highlighting strong performances under exceptional leadership. From Apple’s record revenues to Amazon’s impressive earnings and Intuitive’s standout growth, Scott shares insights on what makes these CEOs and companies ones to watch.

Hier gibt's mehr Infos zur Portfolioanalyse. Aktien hören ist gut. Aktien kaufen ist besser. Bei unserem Partner Scalable Capital geht's unbegrenzt per Trading-Flatrate oder regelmäßig per Sparplan. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden.  Lieber als Newsletter? Geht auch.  Das Buch zum Podcast? Jetzt lesen.  China pumpt über 100 Milliarden in Aktien. JFE und JSW pumpen 440 Millionen in Thyssenkrupp. Boeing pumpt Milliarden an Gehaltserhöhung in das Ende eines Streiks. Und CVS hat zu viele Milliarden in Übernahmen gepumpt. Was haben Ford, John Deere, Toyota und Harley-Davidson gemeinsam? Sie wurden von Robby Starbuck attackiert. Und das überraschend erfolgreich. Intuitive Surgical (WKN: 888024) hat das geilste Abo-Modell der Welt und eine sehr hohe Bewertung. Entsprechend ist die Downside hoch. Aber Costco macht Mut. Diesen Podcast vom 21.10.2024, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

In this episode, Scott Becker covers Netflix’s impressive turnaround, Intuitive Surgical’s strong performance, CVS’s CEO change and stock dip, and American Express’s slight drop despite a strong year. Listen for insights on these key market moves and more.

In this episode, Scott Becker covers Netflix’s impressive turnaround, Intuitive Surgical’s strong performance, CVS’s CEO change and stock dip, and American Express’s slight drop despite a strong year. Listen for insights on these key market moves and more.

In this insightful episode of the Global Medical Device Podcast, host Etienne Nichols is joined by Simon Mason, President of NEST (National Evaluation System for Health Technology), to explore how real-world evidence (RWE) is shaping the future of medical device regulation. Simon breaks down NEST's critical role in catalyzing the use of RWE to streamline submissions, accelerate time-to-market, and lower costs for MedTech companies. With a focus on post-market data, off-label use, and pivotal test cases like pediatric devices and robotic surgery, this conversation reveals the immense potential of RWE to improve patient outcomes and advance medical innovation. Simon also touches on the evolution of NEST since its creation under the FDA's MDUFA commitment and provides real-world examples of how RWE has led to FDA clearances, including collaborations with industry giants like Johnson & Johnson and Intuitive Surgical.Key Timestamps:[00:02:05] – Introduction to Simon Mason and NEST's mission.[00:06:30] – The importance of real-world evidence in medical device submissions.[00:10:50] – NEST's relationship with FDA and industry stakeholders.[00:18:25] – Real-world examples: How RWE led to device clearances.[00:25:10] – Challenges in using real-world data for submissions.[00:32:45] – NEST's role in pediatric devices and the potential for off-label approvals.[00:38:30] – The financial and time-saving benefits of using real-world evidence.[00:50:00] – How companies can engage with NEST to accelerate device approvals.Quotes:Simon Mason: “Real-world evidence has the potential to accelerate device approval and save millions in clinical trial costs. It's all about leveraging existing data to support regulatory submissions.”Etienne Nichols: "The opportunity to use off-label real-world data to expand indications opens a whole new world of innovation for MedTech companies."Simon Mason: “Speed is everything in business and in patient care. RWE is all about moving faster while maintaining safety and effectiveness.”Key Takeaways:Latest MedTech Trends:Real-World Evidence (RWE) Revolution: RWE is transforming regulatory pathways by utilizing data already being collected in real-world settings, reducing the need for costly clinical trials.Off-Label Use for Approvals: NEST is helping companies harness off-label data, particularly in pediatric and robotic surgery, to expand product indications.FDA Collaboration: NEST serves as a bridge between the FDA and industry, simplifying the regulatory process for device companies.Practical Tips for MedTech Innovators:Engage Early: Medical device companies should consider engaging with NEST early in their product lifecycle to identify potential RWE opportunities.Data Accessibility: Companies should explore existing registries or datasets that could support their submissions, saving time and resources.Clear Project Goals: When approaching NEST, companies should have a clear understanding of their product claims and the available data to support them.Questions for Future Development:How will the widespread adoption of RWE change the landscape for early-stage MedTech startups?Can RWE become the default pathway for medical device approvals, replacing traditional clinical trials?What role will AI play in streamlining data collection and analysis for real-world evidence?References:

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Anja Ettel und Holger Zschäpitz über das beste 3. Quartal seit Jahren, Gewinnwarnungen bei Luxus- und Massenkarren und einen durchwachsenen Ausblick der Aida-Aktie. Außerdem geht es um Fedex, UPS, C.H. Robinson Worldwide, ZIM Integrated Shipping, Moller-Maersk, Hapag-Lloyd, CSX, Norfolk Southern, Garmin, Apple, Samsung, DexCom, Global X Internet of things (WKN: A2QPB1), ishares Automation und Robotics (WKN: A2H5ES), Workday, Autodesk, Intuitive Surgical, Constellation, Stellantis, Ashton Martin, Nio und Carnival. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Alissa Coram and Justin Nielsen analyze Monday's market action and discuss key stocks to watch in Stock Market Today.

In this episode, Scott discusses stock performance of major companies like Macy’s, Intuitive Surgical, and Tempus AI, alongside insights into job cuts at big names like Cisco and Google. Plus, a look at the delicate balance of inflation control, strategic business advice, and more.

In this episode, Scott discusses stock performance of major companies like Macy’s, Intuitive Surgical, and Tempus AI, alongside insights into job cuts at big names like Cisco and Google. Plus, a look at the delicate balance of inflation control, strategic business advice, and more.

Ed Carson and Alissa Coram discuss technical action and stocks to watch in the stock market today.

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Philipp Vetter und Holger Zschäpitz über das CrowdStrike-Desaster und den Trump-Index. Außerdem geht es um First Solar, Enphase, Jinko Solar, Solaredge, Maxeon Solar, Brookfield Renewable, Lucid, Rivian, Nextera Energy, Trane Technologies, Carrier Global und Johnson Controls, Oscar Health, Tenet Healthcare, Universal Health Services, DR Horton, United Rentals, The Gap, RWE, Abercrombie & Fitch, Marathon Digital, Hims & Hers, Intuitive Surgical, SentinelOne, Palo Alto Networks, Microsoft, Apple, Amundi S&P 500 VIX Futures Enhanced Roll ETF (WKN: LYX0PM),, Global X Cybersecurity (WKN: A2QPB2), WisdomTree Cybersecurity (WKN: A2QGAH), L&G Russell 2000 US Small Cap Quality ETF (WKN: A0Q8H2), SPDR Russell 2000 U.S. Small Cap ETF (WKN: A1XFN1), Invesco Russell 2000 ETF (WKN: A0RGCT), Xtrackers Russell 2000 ETF (WKN: A1XEJT). Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Aktien hören ist gut. Aktien kaufen ist besser. Bei unserem Partner Scalable Capital geht's unbegrenzt per Trading-Flatrate oder regelmäßig per Sparplan. Alle weiteren Infos gibt's hier: scalable.capital/oaws. Aktien + Whatsapp = Hier anmelden. Lieber als Newsletter? Geht auch. Das Buch zum Podcast? Jetzt lesen. An der Börse gab's am Freitag nur ein Thema: Den IT-Ausfall durch CrowdStrike. Was war da los? Was sind die Effekte? Wer hat Schuld? Wir klären auf. Und danach gibt's Aktivisten bei Starbucks, schwache Zahlen bei Sartorius, intuitives Geldverdienen bei Intuitive Surgical. Der König des Vereinigten Königreichs trinkt den Champagner von Laurent-Perrier (WKN: 923069). Wer kauft die Aktie? Indonesien, Serbien, die Niederlande und die USA. Ahold Delhaize (WKN: A2ANT0) ist überall groß. Die Aktie ist im Vergleich zur Konkurrenz aber ziemlich klein. Diesen Podcast vom 22.07.2024, 3:00 Uhr stellt dir die Podstars GmbH (Noah Leidinger) zur Verfügung.

From Wall Street to Main Street, the latest on the markets and what it means for your money. Updated regularly on weekdays, featuring CNBC expert analysis and sound from top business newsmakers. Anchored and reported by CNBC's Peter Schacknow

In this episode of the Canadian Investor Podcast, we dive into the latest trends and insights shaping the market. First, have a look at the TD Direct Investing Index which shows that investor sentiment is slightly bearish despite markets hitting all time highs. We look at the stocks that have been the most bought and sold by TD's self-directed investors with some surprise names on the list. Switching gears, we share the results of a Twitter poll on the best personal finance hacks. We then talk about a listener's question on when to trim a core position due to high valuation multiples, using Intuitive Surgical as a case study.   Lastly, we explore the concept of battleground stocks—those highly volatile and polarizing stocks that attract both passionate bulls and bears. Using examples like Tesla, Palantir, and Disney, we discuss the risks and rewards of investing in these contentious equities and share lessons learned from their market behavior. Tickers of Stocks & ETF discussed: TSLA, PLTR, DIS, NVDA, GME, TD, BCE.TO, SHOP.TO, AAPL, T.TO, SMCI, AMD Check out our portfolio by going to Jointci.com Our Website Canadian Investor Podcast Network Twitter: @cdn_investing Simon's twitter: @Fiat_Iceberg Braden's twitter: @BradoCapital Dan's Twitter: @stocktrades_ca Want to learn more about Real Estate Investing? Check out the Canadian Real Estate Investor Podcast! Apple Podcast - The Canadian Real Estate Investor  Spotify - The Canadian Real Estate Investor  Web player - The Canadian Real Estate Investor Sign up for Finchat.io for free to get easy access to global stock coverage and powerful AI investing tools. Register for EQ Bank, the seamless digital banking experience with better rates and no nonsense.See omnystudio.com/listener for privacy information.

Are you three to six months past surgery, and finding yourself feeling more hungry? Are you starting to panic? Today we are joined by Dr. Eric Smith and Dr. Sarah Hayek from the Kentucky Bariatric Institute to discuss what is normal when it comes to your hunger cues after recovery. Many people find themselves in a panic that they can suddenly eat more, however throughout this episode you will uncover that it is completely normal and a great sign that you are experiencing hunger and fullness, which is an important sign of recovery. Tune in to understand why it's important to eat more food, and what Dr. Smith and Dr. Hayek would say to a patient who is struggling with eating more.  IN THIS EPISODE: [2:17] Dr. Smith introduces himself.  [3:56] Dr. Hayek introduces herself.  [5:32] What is the relationship between BariNation and Kentucky Bariatric Institute?  [6:42] What was Jason's experience about hunger returning post surgery?  [8:33] Why do people's capacity to eat larger amounts of food change as you recover from bariatric surgery?  [16:28] Why is it important to eat more?  [24:41] Dr. Smith's advice to people who are concerned that they are now able to eat ½ cup to 1 cup of food. [28:04] Dr. Hayek's advice to the same people. KEY TAKEAWAYS: It is normal to start feeling more hungry 3-6 months after surgery, and it's necessary to eat more to fuel your body! Maximizing your nutrition is a major factor in you not only losing weight, but having the best chance to maintain weight loss.  Eating high quality foods will get you fuller faster and for a longer period of time.  RESOURCES: Join the BariNation Membership community meetups to support you on your journey with obesity treatment - https://barination.com/pages/join-our-community Want to see bonus content? Head over to Patreon to get more and to support the podcast for as low as $5 per month! https://www.patreon.com/BariNationPodcast  https://kentuckybariatricinstitute.com/meet-our-team BIOGRAPHY: Dr. Smith's Bio Dr. Eric Smith is a board-certified general and bariatric surgeon who has been in practice since 2006. He is the Medical Director for the Kentucky Bariatric Institute, a SRC Center of Excellence in Robotic Surgery, a national proctor, speaker, and teacher for Intuitive Surgical in the specialty of robotic bariatric surgery. He is board certified in bariatric and robotic surgery, member of the American Society of Metabolic and Bariatric Surgeons. He is an engaged, caring and dedicated physician who has completed thousands of bariatric surgeries. Dr. Hayek's Bio Kentucky Bariatric Institute (KBI) is pleased to welcome Sarah Hayek, MD, to Georgetown and central Kentucky communities. Dr. Hayek will expand the bariatric program's availability by offering robotic bariatric surgery, as well as a number of general surgery procedures. Dr. Hayek completed medical school at Geisinger Commonwealth in Scranton, Pennsylvania and completed residency in general surgery with an additional year in surgical education research at Geisinger Medical Center in Danville, Pennsylvania. She has been a practicing surgeon for over two years with experience and training in general and bariatric robotic surgeries. ABOUT: If the BariNation podcast helps power your bariatric journey, become a monthly podcast supporter and help us produce the show! Visit www.barinationpodcast.com and help us support people treating the disease of obesity with humor, humility, and honesty. BariNation is a bariatric educational organization on a mission to empower patients to access and utilize the tools, resources, and education needed to find and maintain personal wellness. We connect patients with the support they need, when and where they need it. BariNation produces an award-winning weekly podcast distributed on all major podcast and video platforms and hosts a support membership community that teams up with credentialed and licensed bariatric experts and clinicians. BariNation - Website BariNation - Podcast --- Support this podcast: https://podcasters.spotify.com/pod/show/barination/support

In der heutigen Folge von “Alles auf Aktien” sprechen die Finanzjournalisten Daniel Eckert und Holger Zschäpitz über eine US-Aktie, die Rekorde erzielt, obwohl die Heimatbörse zu hat, einen echten Schocker im Dax und einen unverhofften Profiteur der Encavis-Übernahme. Außerdem geht es um iShares Global Clean Energy (WKN: A0MW0M), SMA Solar, Sartorius Vz., Verbio, Thyssenkrupp Nucera, Aixtron, Varta, HelloFresh, Evotec, BMW, Mercedes-Benz Group, Hypport, Encavis, Monster, Apple, Axon Enterprise, Old Dominion Freight, Texas Pacific Land, Constellation Software, Tractor Supply, Intuitive Surgical, ASM, VAT, Comet, Bachem, Schott Pharma, Gerresheimer, Weir Group, Carel, Tecan EngCon, OHB, EQT, SUSE, Bastei-Lübbe, Clearvise, Doc Morris, Edag, Francotyp-Postalia, Jost Werke, SAF Holland, PNE, Norma Group, Stemmer, 2G Energy. Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

EDAP can treat prostate cancer by focusing ultrasound waves at just the target region, similar to how a magnify glass can focus light from the sun so intensely that it can burn a piece of paper, allowing it to eliminate the cancer while limiting side effects, CEO Ryan Rhodes explains to Bloomberg Intelligence. In this Vanguards of Health Care episode, Rhodes sits down with BI analyst Matt Henriksson to talk about his path from Intuitive Surgical to lead EDAP, how the Focal One robot uses high intensity focused ultrasound, or HIFU, to ablate prostate cancer without needing an incision or removing the whole prostate and how the HIFI Study shows that Focal One can be a viable alternative to radical prostatectomy.See omnystudio.com/listener for privacy information.

In this episode of THE MENTORS RADIO, Host Tom Loarie talks with Daniel Hawkins, inventor of intravascular lithotripsy and visionary founder of Shockwave Medical Inc. As the company's founding CEO for nearly 11 years, Daniel led Shockwave through a remarkable journey that culminated in 2024 with an acquisition by Johnson & Johnson for an astounding $13 Billion; the largest acquisition of a medical technology company in history! With a track record that includes being the #6 employee at Intuitive Surgical and driving the first-ever sale of the DaVinci surgical robot, Daniel is a true pioneer in the medical technology field. Join us as we delve into the brutal backstory of creating breakthrough medical technologies, and the personal and professional challenges that come with it. Listen to the show on Salem Radio in San Francisco or via live-streaming on iHeart Radio worldwide… You can also listen on ANY podcast platform, including Apple podcast, iTunes, Spotify, TuneIN, Stitcher, Google Play and all the others. Sign up for the podcast here. SHOW NOTES: DANIEL HAWKINS: BIO: https://www.devicetalks.com/speaker/daniel-hawkins/ LinkedIN: https://www.linkedin.com/in/danielhawkins/ COMPANIES: Shockwave Medical ARTICLES / VIDEO CLIPS: Daniel Hawkins Assumes Command of Vista.ai - news After Intuitive, Shockwave and Avail, Daniel Hawkins is now CEO at AI-powered MRI software startup Vista.ai, news, Mass Device Talk by Daniel Hawkins: The OR (Operating Room) Digital Hub

In der heutigen Folge von „Alles auf Aktien“ sprechen die Finanzjournalisten Daniel Eckert und Nando Sommerfeldt über ein dickes Plus bei der Deutschen Bank und die Favoriten der Megatrend-Fonds. Außerdem geht es um Intel, Snap, Flatex Degiro, Nvidia, Amazon, Intuitive Surgical, ServiceNow, AMD, ASML, TSMC, Toyota, Tesla, Daifuku, Schneider Eletcric, Uber, Aptiv, Albemarle, First Solar, Enphase Energy, Vestas, Ørsted, Linde plc, Trane Technologies, Iberdrola, Air Liquide, NextEra Energy, Apple, SPDR Bloomberg 0-3 Year US Corporate Bond ETF ausschüttend (WKN: A1W3V2) und Xtrackers II EUR Overnight Rate Swap ETF thesaurierend (WKN: DBX0AN). Wir freuen uns an Feedback über aaa@welt.de. Ab sofort gibt es noch mehr "Alles auf Aktien" bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts und AAA-Newsletter.[ Hier bei WELT.](https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html.) Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. Außerdem bei WELT: Im werktäglichen Podcast „Das bringt der Tag“ geben wir Ihnen im Gespräch mit WELT-Experten die wichtigsten Hintergrundinformationen zu einem politischen Top-Thema des Tages. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? [**Hier findest du alle Infos & Rabatte!**](https://linktr.ee/alles_auf_aktien) Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Intuitive Surgical is one of Chip Stock Investor's favorite health tech stocks. It's by far and away the best performing health stock in our portfolio. The revenue growth may look pedestrian, but profitability is poised for continued growth. This company could very well be with us for many years to come! Find out the details in this episode with Chip Stock Investor's "resident nurse" Kasey.

Tech startups are predicted to disrupt US healthcare in 2024. Scott Nelson, co-founder, and CEO of venture backed FastWave Medical, offers his strategies for success in innovation with Jim Cagliostro.    Episode Introduction  Scott reveals the two signs that an idea has potential, why market trumps everything in innovation, and why leaders should focus on eliminating pain points for their end users. He also advises innovators to connect with potential strategic acquirers at an early stage and explains why leaders of startups shouldn't put all their eggs in the venture capital basket.   Show Topics   Two signs of a good idea  Market ultimately trumps everything in innovation Engage with potential strategic acquirers at an early stage Finding investment in your community  Flipping the script: eliminating pain points Effective ways to raise capital Leaders of startups don't have to be the CEO  05:49 Two signs of a good idea  Scott said there are two things for leaders to consider in innovation.  ‘'I guess to answer your question in a little bit more long-winded way, I would say if you've got an idea that you can't seem to shake a little bit… It's sticky and you find yourself maybe waking up at night thinking about it or you thought about it and then two weeks ago you're still thinking about it, maybe a month goes on, you're still thinking about it, that's usually a good signal. Maybe there's something there, but the most important point from my perspective is before you go too far, before you get too latched onto this idea, you really need to think about two things primarily. One, does it solve a real glaring problem? Is it a painkiller? I remember interviewing Dan Hawkins way back in the day. He was actually the founder of Shockwave, the company I mentioned previously, was very early at Intuitive Surgical, was the founder of Avail Medsystems, et cetera, serial entrepreneur. And he phrased, this was back in, I think 2016 or 17, but he mentioned finding a painkiller, not aspirin, not Tylenol, but a real painkiller, something that really causes a lot of pain, whether that's from a cost perspective, whether that's from a workflow perspective, but something that's like, there's a lot of friction there. That's what your idea hopefully solves for, a real painkiller. And then secondarily, if you think you're onto something that solves that real pain point, secondarily, you need to think about this as early in the process as possible. Who's going to pay for it?''   09:03 Market ultimately trumps everything in innovation  Scott explained why market is the #1 factor for potential entrepreneurs.  ‘'I sort of fundamentally believe that market ultimately trumps everything else, right? Now, don't get me wrong, you could have a great product and a great team, but if it doesn't serve a huge market, you're going to have to think about other ways to fund that, right? Maybe it's a product that you can invest your own money in. Maybe it's a product that you can get to market quite quickly and use revenue and profits to support the company's growth, etc. But the reality is you need a big market to serve in order to give you optionality to capitalize and fund your idea or fund the company moving forward. So I do kind of think market trumps everything, because again, you could be working on a great product, have an awesome team, but if the market just doesn't support it, it's likely not going to have a lot of substance there. On the flip side, you could have an awesome market and maybe a decent product and a decent team, but it's probably going to do fairly well because the market supports that need. So, long story short, there's a couple of different ways to think about it. They're all important. ‘'   12:38 Engage with potential strategic acquirers at an early stage ‘'Obviously you need to be careful and cognizant about not disclosing too much, but the imperative is really to start engaging early on with those, what you perceive as potential strategic acquirers, really under the guise of just an introduction. You're not trying to sell them anything. It's a dating process. You're trying to get to know them, inform them of what you're building, what you're working on, so at least have a high-level idea. And as you continue to make progress against your idea and against your milestones, keep them informed. Not just them, but hopefully potential investors, people that... stakeholders within your community. You want to be communicating the progress that you're making against the idea or the product that you're building. So I can come full circle on your question. I just think it's really sometimes underappreciated, and it's actually a tip that I picked up on from Duke Rohlen, he's the founder of Ajax Health, serial entrepreneurs, had multiple exits under his belt, but he mentioned this, in an interview maybe close to 10 years ago now that I had with him. That was one of the things that he really focused on with some of his early wins is really an evaluation of all of the players in a certain market and what are they missing? What are the gaps in their existing portfolios? And he put together a matrix, and that helped think about how his product could potentially fit into the portfolios and where it fits with the broader space, if you will. And so that I think is sometimes maybe a little bit underappreciated from most founders and CEOs that are highly focused on their idea.''   14:38 Finding investment in your community.  Scott said your community could be the source of potential investment.  ‘'Generally speaking… you want to engage with your community as early as possible. In your community could be your end users of your product. Your community could be the payers. Your community could be investors. Your community could be those likely potential strategic acquirers. You need to be engaging with them early, having a lot of conversations early under the guise that you want to let them know who you are, what you're building, what you're working on, and you want to keep them informed on your progress, right? Because if you can demonstrate over the course of six, 12, 18, 24 months that you delivered on what you said you were going to do, that's probably the most impressive thing that you do. You could present a fancy pitch deck, you could have an awesome advisory board. Your product could actually be quite cool, but the thing that's going to stand out is your ability to execute against the things that you say you're going to execute against. That's the most impressive thing. That's always going to stand out to strategic acquirers, investors, even your end user stakeholders. So I really, really think it's important.''   18:41 Flipping the script: eliminating pain points Scott said the key question to ask yourself is how your idea makes life easier for your end users.  ‘'I think oftentimes we might want to flip the script a little bit and not necessarily think about our idea, our technology, offering so many more benefits and so many more improvements. Actually, what does it eliminate from the workflow? What pain points, what friction does it take away from my end users to make their life more simple, more easy to use? And hopefully through that process, we're delivering on those cost savings, right? Because so many times, especially in MedTech, and rightfully so in some scenarios, we think about how to get a pricing bump, or a pricing increase. In reality, your business model might be just delivering a slightly better product, but at a very attractive price. A Costco model. So that's not a bad play. And if your wheelhouse is really more around maybe cogs optimization or supply chain management, and that's what you really know well, there could be some great ideas in there where you can just simply deliver a good enough product, maybe slightly better, but just at a very attractive price. And that could be a phenomenal idea. And so I think those are a couple of things that I would think about under the guise of how do I differentiate myself versus competition? Don't think about your product doing so many great things. Think about how it can remove friction in a process and make your end users' lives more simple, more easy, less stressful. And then maybe just as important, how can it remove costs from the equation?''   22:30 Effective ways to raise capital Scott said innovators need to be thinking in terms of major milestones about fundraising.  ‘' I'll probably say fairly high level, but I really would encourage everyone to think about how they're raising capital. Think about it in cycles, if you will. You want to raise enough capital, ideally, not too much per se, but not too little either. But raise enough capital where you can achieve the next major milestone in say, 12 months. And you need to make that very, very clear to all your potential investors, this is what we're raising our money for. This is the next major milestone that we're targeting. So being very, very clear about that and kind of thinking about your fundraising and tranches, if you will, like that. And again, it is really very important. Yes, you want to be in a position where you don't run out of cash for sure, but you also don't want to take so much money upfront that you get so diluted that will impact future fundraisers. So yes, think about these near-term milestones. Those are crucial, but also think about how those may impact the next fundraise as well. So I definitely want to, I'd like to start out there because I think it's a point worth emphasizing for anyone that's working on early stage technology.''   26:03 Leaders of startups don't have to be the CEO  ‘'I think as leaders of startups, you don't necessarily have to be the CEO. If you're in some sort of leadership capacity within an early stage company, I would just keep in mind that when you're trying to direct your team and push the ball forward, but you're pushing in essence a boulder uphill with a lot of friction, momentum is crucial. So as a leader, you need to keep that in mind, is do everything within your power to keep the momentum going forward. There's always going to be trade-offs as your company evolves, but ensuring and optimizing for momentum, that's so, so crucial. So that's probably one of the things that probably stands out most as part of this broader startup idea.''   Connect with Lisa Miller on LinkedIn Connect with Jim Cagliostro on LinkedIn Connect with Scott Nelson on LinkedIn    Check out VIE Healthcare and SpendMend    You'll also hear:    Three things for every innovator to consider: ‘'As your idea begins to evolve and begins to take shape, you need to be thinking about…what product am I building? What market does it serve? And who's the best team to effectively build this?'' One key piece of advice for startups: ‘'As a startup, if you're working on an idea, the most likely scenario for a potential liquidity event is an exit to a strategic acquirer.'' The blurred line between payers and providers: ‘'Once my technology is approved or cleared by the regulatory body and I'm ready to sell, then I need to think about who's going to pay for it. Well, the reality is … the lines between payers and providers, is really, quite blurred… They ought to know who you are and what you've been building for hopefully months, if not maybe a couple of years.'' Don't put your eggs all in the traditional VC basket: ‘'If you're so highly dependent upon traditional VCs, likely they're going to get squeezed…. So the onus on founders, CEOs, in terms of fundraising is to keep a lot of options on the table, go far and wide. It's a lot of work.''   What To Do Next:   Subscribe to The Economics of Healthcare and receive a special report on 15 Effective Cost Savings Strategies.   There are three ways to work with VIE Healthcare:   Benchmark a vendor contract – either an existing contract or a new agreement. We can support your team with their cost savings initiatives to add resources and expertise. We set a bold cost savings goal and work together to achieve it.  VIE can perform a cost savings opportunity assessment. We dig deep into all of your spend and uncover unique areas of cost savings.  If you are interested in learning more, the quickest way to get your questions answered is to speak with Lisa Miller at lmiller@spendmend.com or directly at 732-319-5700.

Today, we are breaking down a giant in the medical device space, Intuitive Surgical. Intuitive creates robotic products to assist minimally invasive surgeries. Its Da Vinci system is a pioneer in this area as it increases the efficiency & accuracy of surgery and reduces the burden on the surgeons themselves. To break down Intuitive, I'm joined by Joseph Thomas, equity analyst at the global asset manager, Ninety One. Joe walks us through the history of surgical procedures, the emergence of robotics & surgery, and how Intuitive has emerged as the winner in this space. Please enjoy this breakdown on Intuitive Surgical. Interested in hiring from the Colossus Community? Click here. For the full show notes, transcript, and links to the best content to learn more, check out the episode page here. ----- This episode is brought to you by Tegus, the only investment research platform built for the investor. With traditional research vendors, the diligence process is slow, fragmented, and expensive. That leaves investors competing on how well they can aggregate data — not on their unique ability to analyze insights and make great investment decisions. Tegus offers an end-to-end platform with all the data you need to get up to speed on a company or market: up-to-the-minute financials, customizable models, management and culture checks, and, of course, our vast and growing library of expert call transcripts. Tegus is changing the world of expert research. Learn more and get your free trial at tegus.com/patrick. ----- Business Breakdowns is a property of Colossus, LLC. For more episodes of Business Breakdowns, visit joincolossus.com/episodes. Stay up to date on all our podcasts by signing up to Colossus Weekly, our quick dive every Sunday highlighting the top business and investing concepts from our podcasts and the best of what we read that week. Sign up here. Follow us on Twitter: @JoinColossus | @patrick_oshag | @zbfuss | @ReustleMatt | @domcooke Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). Show Notes (00:00:00) Welcome to Business Breakdowns (00:02:55) First Question - The Evolution of Surgery: From Ancient Practices to Robot-Assisted (00:08:14) Revolutionizing Surgery With the Da Vinci System (00:11:23) Early Challenges and Regulatory Hurdles for Robotic Surgery (00:14:59) The Future of Robotic Surgery (00:22:40) Exploring the Business Model of Intuitive Surgical (00:29:26) The Fifth Generation of the Da Vinci System (00:37:26) Intuitive Surgical's Financial Overview (00:41:16) Depreciation, Secondary Markets, and Economic Factors (00:45:52) R&D Investments and Digital Innovations (00:49:04) Navigating the Competitive Landscape (00:55:04) Global Expansion and Market Opportunities (00:57:27) Identifying Risks and Disruptions (01:01:37) Key Lessons from Intuitive Surgical Learn more about your ad choices. Visit megaphone.fm/adchoices

The post-Covid surgery backlog is fueling Intuitive Surgical to strong preliminary earnings results, and the CEO of Burford Capital talks through their unique niche in the legal space. (00:21) Jason Moser and Dylan Lewis discuss: - The SEC's pending decision on crypto spot ETFs and the agency's X account getting hacked. - Potential regulations coming for the gig economy and workers that are heavily reliant on companies like Uber, Lyft, and DoorDash. - An early earnings look for Intuitive Surgical, and why surgery activity has normalized post-COVID. (12:48) Burford Capital CEO Chris Bogart walks analyst Rich Griefner through the world of legal financing, his company's competitive advantages, and a high-stakes case with Argentina. Companies discussed: UBER, LYFT, DASH, AMXZN, BUR Host: Dylan Lewis Guests: Jason Moser, Rich Griefner, Engineers: Dan Boyd, Dez Jones Learn more about your ad choices. Visit megaphone.fm/adchoices

Investing has plenty of rules. Don't invest in stocks without earnings. Sell half your position after a stock doubles. But, who made those rules anyway? Ricky Mulvey caught up with Rule Breakers Lead Advisor Tim Beyers and The Motley Fool's co-founder and Chief Rule Breaker David Gardner to discuss: - What makes a business a Rule Breaker. - Investing lessons from Apple, Tesla, and Intuitive Surgical. - How to invest like a venture capitalist. - Creating your own investing rules. - What risk actually means for an investor. Companies mentioned: TSLA, ISRG, AAPL, SNOW, CRM, TOST Host: Ricky Mulvey Guests: David Gardner, Tim Beyers Engineer: Tim Sparks